Our Managing Director Andreas Trumpp was interviewed in Rhein Neckar Zeitung about our recent publication in Nature on neural innervation of tumors and their medical implications.
Read the interview here:
Our Managing Director Andreas Trumpp was interviewed in Rhein Neckar Zeitung about our recent publication in Nature on neural innervation of tumors and their medical implications.
Read the interview here:
Else Kröner Fresenius Foundation awarded one of this year's Else Kröner Memorial Fellowships to HI-STEM Group Leader Mirco Friedrich. This fellowship provides two years of protected time away from clinical duties to clinician scientists to focus on their research projects. Dr. Friedrich is working on an mRNA-based strategy designed to temporarily empower the immune system, which could help overcome immune decline and enhance health-span in our aging societies.
The German Research Foundation (DFG) will support the new Collaborative Research Center (SFB) 1709 “Cellular Plasticity in Malignant Myeloid Diseases – From Mechanism to Therapy” over the next four years. In around 20 working groups, scientists will investigate how and why certain leukemia cells change during the course of the disease and during therapy. The aim is to break their resistance to therapy in the future or prevent it from developing in the first place. HI-STEM managing director Prof. Dr. Andreas Trumpp is co-speaker of the collaborative research center and three HI-STEM group leaders are contributing to it with individual projects.
Mirco Julian Friedrich, Junior Group Leader at HI-STEM, DKFZ and Heidelberg University Hospital (UKHD) has been included in the prestigious Forbes list “30 Under 30 Europe” in the Science & Healthcare category.
The physician and cancer researcher, who has been heading the Junior Research Group Hematology and Immune Engineering since this year, initially developed successful approaches to reactivating the immune system against brain tumors.
With his current research, Friedrich aims to develop innovative strategies for reprogramming the human immune system by integrating synthetic immunology, genome editing, and AI-driven bioengineering. The goal is to prevent cancer, strengthen immune resilience, and promote healthy aging.
With this award, the US business magazine Forbes annually honors outstanding young people under the age of 30 who have made a mark in their fields through innovation, social relevance, and exceptional achievements.